stars 1 stars 2 stars 3

Novus Capital is a leading regional investment banking firm in pharmaceutical industry with geographic focus on Russia, the CIS and the Baltic States. Novus Capital professionals have a broad experience in advising owners and foreign investors in M&A transactions and related activities (due diligence, structuring, negotiations etc.). In recent years our team executed a number of cross border transactions in pharmaceutical industry with total value of USD 450 m, making our team the leading financial adviser to pharmaceutical companies in Russia

Novus Capital Questions

The Novus Capital annual revenue was $4 million in 2026.

Aleksandr Lobakov is the Managing Partner of Novus Capital.

12 people are employed at Novus Capital.

Novus Capital is based in Moscow, Moscow.

The NAICS codes for Novus Capital are [523110, 52311, 52, 5231, 523].

The SIC codes for Novus Capital are [62].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users